Tracking Multidrug Resistance in Gram-Negative Bacteria in Alexandria, Egypt (2020–2023): An Integrated Analysis of Patient Data and Diagnostic Tools
Authors:
- Sascha D. BraunSBSascha D. Braun
- Shahinda RezkSRShahinda Rezk
- Christian BrandtCBChristian Brandt
- Martin ReinickeMRMartin Reinicke
- Celia DiezelCDCelia Diezel
- Elke MüllerEMElke Müller
- Katrin FrankenfeldKFKatrin Frankenfeld
- Domenique KrähmerDKDomenique Krähmer
- Stefan MoneckeSMStefan Monecke
- Ralf EhrichtRERalf Ehricht
Open Access
- 5 December 2024
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 13 (12) , 1185
Abstract
Background: The rise in carbapenem-resistant Enterobacteriaceae (CRE) in Egypt, particularly in hospital settings, poses a significant public health challenge. This study aims to develop a combined epidemiological surveillance tool utilizing the Microreact online platform (version 269) and molecular microarray technology to track and analyze carbapenem-resistant Escherichia coli strains in Egypt. The objective is to integrate molecular diagnostics and real-time data visualization to better understand the spread and evolution of multidrug-resistant (MDR) bacteria. Methods: The study analyzed 43 E. coli isolates collected from Egyptian hospitals between 2020 and 2023. Nanopore sequencing and microarray analysis were used to identify carbapenemase genes and other resistance markers, whereas the VITEK2 system was employed for phenotypic antibiotic susceptibility testing. Microreact was used to visualize epidemiological data, mapping the geographic and temporal distribution of resistant strains. Results: We found that 72.09% of the isolates, predominantly from pediatric patients, carried the blaNDM-5 gene, while other carbapenemase genes, including blaOXA-48 and blaVIM, were also detected. The microarray method demonstrated 92.9% diagnostic sensitivity and 87.7% diagnostic specificity compared to whole-genome sequencing. Phenotypic resistance correlated strongly with next-generation sequencing (NGS) genotypic data, achieving 95.6% sensitivity and 95.2% specificity. Conclusions: This method establishes the utility of combining microarray technology, NGS and real-time data visualization for the surveillance of carbapenem-resistant Enterobacteriaceae, especially E. coli. The high concordance between genotypic and phenotypic data underscores the potential of DNA microarrays as a cost-effective alternative to whole-genome sequencing, especially in resource-limited settings. This integrated approach can enhance public health responses to MDR bacteria in Egypt.Keywords
Funding Information
- Federal Ministry of Education and Research (13GW0458D, LPI-BT5 Leibniz IPHT 13N15717)
- Photonics Research Germany (13GW0458D, LPI-BT5 Leibniz IPHT 13N15717)
This publication has 64 references indexed in Scilit:
- Analysis of carbapenem-resistant strains isolated in a tertiary care hospital in Rawalpindi, Pakistan, during the years 2016 and 2020Journal of Hospital Infection, 2023
- Web-based prediction of antimicrobial resistance in enterococcal clinical isolates by whole-genome sequencingEuropean Journal of Clinical Microbiology & Infectious Diseases, 2022
- Multidrug-Resistant Bacteria in the CommunityInfectious Disease Clinics of North America, 2020
- The emergence of carbapenemase blaNDM genotype among carbapenem-resistant Enterobacteriaceae isolates from Egyptian cancer patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2020
- Travel and the Spread of Drug-Resistant BacteriaCurrent Infectious Disease Reports, 2018
- A 72-h intervention for improvement of the rate of optimal antibiotic therapy in patients with bloodstream infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2017
- High-level carbapenem-resistant OXA-48-producing Klebsiella pneumoniae with a novel OmpK36 variant and low-level, carbapenem-resistant, non-porin-deficient, OXA-181-producing Escherichia coli from ThailandDiagnostic Microbiology and Infectious Disease, 2016
- Characterization of carbapenemases, extended spectrum β-lactamases, quinolone resistance and aminoglycoside resistance determinants in carbapenem-non-susceptible Escherichia coli from a teaching hospital in Chongqing, Southwest ChinaInfection, Genetics and Evolution, 2014
- NDM-1- and OXA-163-producing Klebsiella pneumoniae isolates in Cairo, Egypt, 2012Journal of Global Antimicrobial Resistance, 2013
- Plasmid-mediated quinolone resistance determinants qnr and aac(6′)-Ib-cr in Escherichia coli and Klebsiella spp. from Norway and SwedenDiagnostic Microbiology and Infectious Disease, 2010